High Net Worth Advisory Group LLC acquired a new stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 2,422 shares of the financial services provider’s stock, valued at approximately $534,000.
A number of other hedge funds also recently added to or reduced their stakes in the business. Centaurus Financial Inc. increased its holdings in shares of CME Group by 24.3% in the 4th quarter. Centaurus Financial Inc. now owns 686 shares of the financial services provider’s stock valued at $144,000 after acquiring an additional 134 shares during the period. Syon Capital LLC grew its stake in shares of CME Group by 8.6% during the fourth quarter. Syon Capital LLC now owns 1,986 shares of the financial services provider’s stock worth $418,000 after acquiring an additional 158 shares during the last quarter. SageView Advisory Group LLC raised its position in shares of CME Group by 30.6% in the 4th quarter. SageView Advisory Group LLC now owns 3,888 shares of the financial services provider’s stock valued at $801,000 after purchasing an additional 910 shares during the last quarter. MONECO Advisors LLC purchased a new stake in CME Group during the 4th quarter worth approximately $227,000. Finally, B. Riley Wealth Advisors Inc. grew its position in CME Group by 1.3% during the 4th quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock worth $782,000 after purchasing an additional 48 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.
CME Group Stock Performance
CME opened at $221.72 on Monday. The stock has a market cap of $79.83 billion, a P/E ratio of 25.22, a P/E/G ratio of 7.76 and a beta of 0.55. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a fifty day moving average price of $214.61 and a 200 day moving average price of $207.88. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $226.78.
CME Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were given a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 52.33%.
Analyst Ratings Changes
CME has been the subject of a number of research analyst reports. Citigroup raised their price target on shares of CME Group from $240.00 to $250.00 and gave the stock a “buy” rating in a report on Thursday, October 3rd. The Goldman Sachs Group boosted their price target on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research note on Thursday, October 3rd. Piper Sandler increased their price objective on CME Group from $225.00 to $240.00 and gave the company an “overweight” rating in a report on Tuesday, October 8th. Bank of America lifted their target price on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday, October 3rd. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $235.00 price target on shares of CME Group in a report on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $217.71.
Check Out Our Latest Analysis on CME
Insider Transactions at CME Group
In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
- Five stocks we like better than CME Group
- CD Calculator: Certificate of Deposit Calculator
- 3 Stocks Under $20 for Buy-and-Hold Investors Seeking Growth
- ETF Screener: Uses and Step-by-Step Guide
- BlackRock’s Earnings Reveal Market Shift: Why Bonds Are in Favor
- Conference Calls and Individual Investors
- JPMorgan Can Hit New Highs This Year: Here’s Why
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.